SPARQL
Query
Update
Search
Quick
Advanced
Co-occurrence
RelFinder
About
Sources
Admin
System Info
Repository Management
Search Configuration
Sources
17100941
Source:
http://linkedlifedata.com/resource/pubmed/id/17100941
Search
Subject
(
44
)
Predicate
Object
All
Download in:
JSON
RDF
N3/Turtle
N-Triples
Switch to
Custom View
Named Graph
All
UniProt
NCBIGene
DrugBank
ClinicalTrials
UMLS
PubMed
Mappings
MentionedEntities
Language
All
English
Español
Português
Français
Deutsch
Русский
日本語
Български
Inference
Explicit and implicit
Explicit only
Implicit only
Statements in which the resource exists as a subject.
Predicate
Object
rdf:type
pubmed:Citation
lifeskim:mentions
umls-concept:C0033117
,
umls-concept:C0034897
,
umls-concept:C0205464
,
umls-concept:C0679717
,
umls-concept:C1318700
,
umls-concept:C1524063
pubmed:issue
6
pubmed:dateCreated
2006-11-14
pubmed:abstractText
Recurrent ischemic priapism is an enigmatic erectile disorder in need of improved clinical interventions to avert its known, potentially serious complications.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/17100941-17855853
pubmed:language
eng
pubmed:journal
http://linkedlifedata.com/resource/pubmed/journal/101230693
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/3',5'-Cyclic-GMP Phosphodiesterases
,
http://linkedlifedata.com/resource/pubmed/chemical/Cyclic Nucleotide...
,
http://linkedlifedata.com/resource/pubmed/chemical/PDE5A protein, human
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1743-6095
pubmed:author
pubmed-author:BivalacquaTrinity JTJ
,
pubmed-author:BurnettArthur LAL
,
pubmed-author:ChampionHunter CHC
,
pubmed-author:MusickiBiljanaB
pubmed:issnType
Print
pubmed:volume
3
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1077-84
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:17100941-3',5'-Cyclic-GMP Phosphodiesterases
,
pubmed-meshheading:17100941-Adult
,
pubmed-meshheading:17100941-Cyclic Nucleotide Phosphodiesterases, Type 5
,
pubmed-meshheading:17100941-Humans
,
pubmed-meshheading:17100941-Male
,
pubmed-meshheading:17100941-Penile Erection
,
pubmed-meshheading:17100941-Priapism
,
pubmed-meshheading:17100941-Recurrence
,
pubmed-meshheading:17100941-Severity of Illness Index
,
pubmed-meshheading:17100941-Treatment Outcome
pubmed:year
2006
pubmed:articleTitle
Feasibility of the use of phosphodiesterase type 5 inhibitors in a pharmacologic prevention program for recurrent priapism.
pubmed:affiliation
Johns Hopkins University-Urology, Baltimore, MD, USA. aburnett@jhmi.edu
pubmed:publicationType
Journal Article